Академический Документы
Профессиональный Документы
Культура Документы
Corporate Profile
March 2013
1
1
Agenda
Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Growth Strategy
Recent Performance
2
2
Established
E
t bli h d iin 1884 - more than
th
125
Years of Trust & Excellence
g
in Ayurveda
y
and natural
Worlds largest
healthcare
g
distribution networks
One of the largest
covering 5.8 million retailers across India
Twelve
l
Billion
illi
Rupee Brands
d
Dabur ranked as
Most Trusted
HealthCare,
Ayurveda brand in
India
Dabur moves up
15 places, ranked
186 in Fortune
India 500 list
Ranked
amongst Top
100 Most
Exciting Brands
in India
3
3
Ownership
Passion for
Winning
Integrity
Core
Values
Innovation
Team Work
People
Development
Consumer
Focus
4
4
Key Milestones
1884
1972
1986
Dr. SK Burman
started an Ayurvedic
Pharmacy in Kolkatta
The company
shifted base to
Delhi from Kolkata
Registered as
Public Limited
Company
1994
1998
2003
Listed on the
B
Bombay
b
Stock
St k
Exchange
Professionalized with
B
Burman
Family
F
il handing
h di
over day to
management
Pharmaceutical Business
d
de-merged
d to
t focus
f
on core
FMCG business
2004
2005
2006
International
Business set up in
Dubai to tap overseas
opportunity
Acquired Balsara
strengthening Oral
care & gaining entry
into Home care
2008
2010
2012
Overseas acquisitions -
Crossed Rs. 50 bn
mark in annual
revenues and Market
Cap of c. US$4 billion
p, Turkey
y and
Hobi Group,
Namaste Laboratories, US
5
5
5.7
5.0
40.8
28.1
3.9
33.9
3.3
23.6
FY08
FY09
FY10
FY11
FY12
EBITDA (Rs.
(R billion)
billi )
FY08
FY09
FY10
FY11
FY12
Sh
Shareholders
h ld
F
Funds
d (R
(Rs. billion)
billi )
9.5
17.2
8.3
13.9
6.7
4.4
5.2
8.2
9.3
6.2
FY08
FY09
FY10
FY11
FY12
FY08
FY09
FY10
FY11
FY12
6
6
Global Footprint
Distribution Overview
Factory
Depot
Stockists
Insti Stockists
Super stockists
Modern Trade
Stockist
Wholesalers
Retail trade
Military / CSD
Sub stockists
Rural trade
Unit Canteens
Insti customers
Direct reach
0.8 mn outlets
3rd largest distribution network with a total reach of 5.8 mn retail outlets
8
9 OTC Healthcare
9
9
Agenda
Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Growth Strategy
Recent Performance
10
10
2,500
2,000
1,626
1 895
1,895
1,200
1,500
1,000
500
0
MATSep'11
MATSep'12
1 262
1,262
1 400
1,400
1,082
800
700
600
1,000
500
800
400
600
300
400
200
200
100
MATSep'11
MATSep'12
544
MATSep'11
633
MATSep'12
Source:ACNielsen
Overview
9 FMCG sector in India continues to grow well in both urban and rural areas. Rural
India contributes to c.
c one third of FMCG sales in India
9 Growth driven by increasing consumption led by rise in incomes, changing
lifestyles and favorable demographics
9 As per a study conducted by Booz & Company, FMCG sector is expected to grow
in the range of 12% to 17% upto 2020 and would touch a market size between of
Rs. 4,000 to Rs. 6,200 billion by 2020
11
11
UrbanPenetration
90%
80%
80%
77%
67%
70%
50%
59%
57%
60%
42%
40%
37%
32%
26%
30%
18%
20%
19%
18%
10%
3%
2%
5%
4%
0%
Toothpaste
Shampoo
HairOil
SkinCream
Mosquito
Repellants
Instant
Noodles
HairDyes
FloorCleaners
Source:Industrydata
9 Low penetration levels offer room for growth across consumption categories
9 Rural penetration still lower but catching up with urban penetration levels
12
12
in US$
9
77
7.7
7.4
27
2.7
3
2.5
2.4
7
2
6
5
4
1.5
3.2
1.1
1.0
3
2
0.8
0.3
0.5
0.3
China
Indonesia
India
Malaysia
China
Thailand
Indonesia
India
Malaysia
Thailand
2.9
3
2.5
20
2.0
2
1.5
1
1.0
0.5
0.4
0.5
0
China
Indonesia
India
Malaysia
Thailand
Source: MOSL
13
13
Key Categories
Sales
Profit
Market Cap
Soaps, Detergents,
Personal Care,
Care Foods
229,877
,
27,907
,
975,094
,
83,023
10,679
455,564
52 832
52,832
6 449
6,449
233 640
233,640
Godrej Consumer
48,509
7,267
248,455
26,239
4,465
184,447
30,794
4,368
177,802
Marico Ltd.
39,968
3,171
140,394
Biscuits
54,607
1,995
59,422
Feminine Hygiene,
personal care
12,947
1,813
81,151
Market Cap
Cap. as of March 5
5, 2013
14
14
Position
Market Share
Key Brands
Hair Care
12%
Oral Care
13%
Ayurvedic
Tonics
67%
Dabur Chyawanprash
Digestives
56%
Hajmola
Fruit Juices
55%
Honey
50%
Dabur Honey
Glucose
25%
Dabur Glucose
Skin Care
(Bleaches)
50%
Fem
Air Freshener
40%
Odonil
Hair care includes Hair Oils & Shampoos; Oral care includes Toothpastes & Toothpowder; Digestives includes herbal digestives
15
15
Agenda
Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Growth Strategy
Recent Performance
16
16
Business Structure
Dabur India
Limited
International
Business (30.3%)
Domestic Business
(69.7%)
Consumer
Care
(56 0%)
(56.0%)
Foods
(10.1%)
(
)
Retail
(0.8%)
(
)
Others*
(2.7%)
(
)
Dabur
International
(17 5%)
(17.5%)
Hobi
Group
(2 6%)
(2.6%)
Namaste
Labs. LLC
(10 3%)
(10.3%)
17
17
OralCare
17%
SkinCare
6%
HomeCare
6%
HairCare
30%
Health
Supplements
21%
Digestives
8%
OTC&Ethicals
12%
9 Hair Care is the largest category and contributes to 29% of Consumer Care sales
9 Health Supplements contribute to 22% of Consumer Care sales
9 Oral Care, comprising toothpastes and toothpowders contributes to 18% of
Consumer Care sales
18
18
#2 player in
Hair Oils
Dabur Amla:
Largest brand in
the portfolio
Shampoo
Key Brands
#4 player in
Shampoos
#3 player in
Toothpastes
#2 player in
Toothpowder
Babool: Targeted at
economy segment
Meswak: Premium
therapeutic
toothpaste
Skin Care
Key Brands
#1 player
l
in
i
Skin Care
(Bleaches)
Fem range of Bleaches
Gulabari
G
l b i range off
rose based skin
care products
Uveda:
U
d Range
R
off
Ayurvedic Skin
Care
20
20
#1 player in Air
Fresheners
#1 p
player
y
in
Mosquito Repellant
Creams
#2 player
l
in
i Toilet
T il t
Cleaners
Odomos: Mosquito
repellant
ll t skin
ki cream
Sanifresh:
Toilet cleaner
#1 player in
Ayurvedic
y
Tonics
#2 player in
Glucose
#1 player in
branded Honey
Dabur Chyawanprash:
Largest selling health
supplement in the
country
Dabur Glucose:
2nd largest
player in the
country
Digestives
Key Brands
#1 player in
Herbal
Digestives
Hajmola: Flagship brand
for branded Digestives
Hajmola tasty
digestive candy
22
22
Lal Tail
Honitus
Janma Ghunti
Dashmularishta
Ashokarishta
23
23
Foods Business
9 Foods portfolio comprises Juices and Culinary range
9 Juices are under the brands Real, Activ and Burrst
9 Culinary range is under Hommade brand
9 Foods business has surpassed the Rs. 5 billion mark in sales
Foods
Key Brands
#1 player in
Fruit Juices
Real:
R
l Fl
Flagship
hi
beverages brand
24
24
International Business
Started as an
Exporter
Focus on Order
fulfillment through
India Mfg.
1980s
Set up a franchisee at
Dubai in 1989
Demand generation
led to setting up of
mfg in Dubai & Egypt
Early 90s
2003 Onwards
Highlights
Building scale
scale- c.
c 30% of
Consol. Sales
High Levels of Localization
Global Supply chain
Today
in Rs
Rs. million
16,161
16000
14000
12000
8,922
10000
8000
6000
4000
2000
2,258 2,917
1,281 1,807
3 760
3,760
4,770
,
6,025
25
25
Source: IMF
9 Middle East and Africa have witnessed stable GDP growth rates
9 Between 2005 and 2015, it is estimated that in Africa, the share of individuals earning
above US$1,000 will grow from 39% to 55%.
9 The rapidly emerging African middle class could number as many as 300 million, out of a
total population of one billion
9 The sheer volumes and the growth in the number of aspirational consumers with
disposable income creates huge opportunities for consumer products companies
26
26
is
27
27
28
28
Agenda
Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Growth Strategy
Recent Performance
29
29
Growth Strategy
Three pronged Growth Strategy
Expand
Innovate
Acquire
Odonil Gels
31
31
31
Vatika Enriched
Hair Oil Black
Seed
Dabur Medicated
Toothpaste
Vatika
Professional
Range
g
32
32
32
Agenda
Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Growth Strategy
Recent Performance
33
33
EBITDA
(inRs.Cr.)
PAT*
(inRs.Cr.)
34
34
Shareholding Structure*
231,800
DIIs,5.1%
Others,
6.6%
FIIs 19 6%
FIIs,19.6%
137,997
22,403
31,760
Mar2000
Mar2005
Promoters,
68.7%
Mar2010
Feb2013
*As of Dec 31, 2012
Daburhaswitnessedexponentialincreaseinmarketcapitalizationovertheyears
Atpresent,DaburhasamarketcapofINR234billion(asofMarch5,2013)
35
35
Consolidated P&L
IInRs.mn
R
NetSales
OtherOperatingIncome
MaterialCost
%ofSales
EmployeeCosts
%ofSales
AdPro
%ofSales
OtherExpenses
%ofSales
OtherNonOperatingIncome
EBITDA
%ofSales
InterestExp.andFin.Charges
Depreciation&Amortization
ProfitBeforeTax(PBT)
ExceptionalItem
TaxExpenses
ProvisionforTaxationforEarlieryears
PAT(Beforeextraordinaryitem)
%ofSales
ExtraordinaryItem
PAT(AfterextraordinaryItems)
y
((Profit)/Loss
)/
MinorityInterest
PAT(AfterExtraord.item&Min.Int)
%ofSales
Q3FY13
16,307.2
52.6
7,953.6
48.8%
1,229.5
7.5%
2,350.5
14.4%
2,081.1
12.8%
220.3
2,965.4
18.2%
77.8
305.2
2,582.4
0.0
477.5
Q3FY12
14,526.8
46.0
7,404.0
51.0%
1,025.4
7.1%
1,982.4
13.6%
1,851.6
12.7%
167.1
2,476.6
17.0%
182.9
238.5
2,055.1
0.0
336.9
YoY(%)
Y
Y (%)
12.3%
2104.8
12.9%
0.0
2104.8
6.2
2111.1
12.9%
1718.3
11.8%
0.0
1718.3
10.0
1728.3
11.9%
22.5%
7.4%
19.9%
18.6%
12.4%
31.8%
19.7%
57.5%
27.9%
25.7%
41.8%
22.5%
22.1%
9MFY13
46,152.9
171.8
22,794.7
49.4%
3,503.3
7.6%
6,450.6
14.0%
6,006.6
13.0%
715.2
8,284.6
18.0%
439.2
842.4
7,003.0
46.6
1319.5
9MFY12
39,195.9
139.7
20,075.1
51.2%
2,917.9
7.4%
4,774.7
12.2%
4,985.9
12.7%
460.4
7,042.5
18.0%
481.2
739.1
5,822.1
0.0
1086.5
5637.0
12.2%
0.8
5637.8
9.1
5628.7
12.2%
4735.7
12.1%
0.0
4735.7
8.2
4743.9
12.1%
YoY(%)
Y
Y (%)
17.7%
13.5%
20.1%
35.1%
20.5%
55.3%
17.6%
8.7%
14.0%
20.3%
21.4%
#DIV/0!
19.0%
19.0%
18.7%
36
36
20 542
20,542
17 172
17,172
106
30
5,497
322
0
6,569
12,388
6,830
274
0
5,799
12,904
3,728
5,138
8,636
1,579
,
19,082
52,117
3,409
2,581
7,713
2,415
,
16,117
46,223
9,930
7,807
997
0
4,382
1,844
24,960
8,873
7,807
893
0
3,935
1,019
22,527
5,446
7,340
5,836
4,350
3,638
548
27,158
52,118
3,932
8,239
4,617
4,184
2,401
322
23,696
46,223
37
37
Recent Accolades
38
38
Disclaimer
Some of the statements made in this presentation contain forward looking information that involve a
number of risks and uncertainties.
uncertainties Such statements are based on a number of assumptions,
assumptions estimates,
estimates
projections or plans that are inherently subject to significant risks, as well as uncertainties and
contingencies that are subject to change. Actual results can differ materially from those anticipated in the
Companys forwardlooking statements as a result of a variety of factors, including those set forth from
time to time in the Companys press releases and reports and those set forth from time to time in the
Companys
p y analyst
y calls and discussions. We do not assume anyy obligation
g
to update
p
the forwardlookingg
statements contained in this presentation.
No part of this presentation shall form the basis of or may be relied upon in connection with any contract
or commitment. This presentation is being presented solely for your information and is subject to change
without notice.
39
39
Investor Relations
Dabur India Ltd
Contact:+91-11-42786000
40
40